"Should I wait for Mounjaro to get cheaper?" is one of the most common questions we hear. It is a fair one — and the honest answer is that nobody can promise a price drop, including us. What we can do is set out what is actually known: what has happened to prices elsewhere, what generics would need to happen first, and what is realistically in the pipeline. Here is the calm version.
Quick answer (October 2026)
There is no announced price cut for Mounjaro in Ireland, and no generic tirzepatide has launched anywhere in the world. Where prices have moved recently, the direction has been up, not down — Lilly raised UK private list prices in September 2025. Patent protection and regulatory timelines mean cheaper copies are not a near-term certainty. Newer options may widen choice over time, but that is different from a guaranteed lower price. See if a doctor-led programme suits you.
Try the Slimbr weight loss plan
First month service fee just €49. If the doctor decides it's not suitable for you, your doctor consultation is free.
What has actually happened to Mounjaro prices?
The most recent real price movement we can point to is in the UK. Lilly confirmed in August 2025 that private list prices for Mounjaro pens would rise from 1 September 2025, with UK sales briefly paused to prevent stockpiling ahead of the change. The reported range moved from roughly £92–£122 to roughly £133–£330 depending on the dose, and Lilly said the aim was to address pricing inconsistencies with other developed countries (Yahoo News, 14 August 2025; TheJournal.ie, 28 August 2025).
| Strength (monthly pen) | Until 31 Aug 2025 | From 1 Sep 2025 |
|---|---|---|
| Lower strengths | from ~£92 | from ~£133 |
| Highest strength (15mg) | ~£122 (~€141) | ~£330 (~€382) |
Figures as reported at the time of the August 2025 announcement; UK private list prices before any pharmacy discounts. Irish prices are set separately and vary by supplier.
For Ireland, the picture was different. When the UK change was reported, a representative for Eli Lilly confirmed to TheJournal.ie that the company had no plans for price increases or a corresponding sales pause here — and the highest dose was reported at the time to cost around €475 a month in Irish pharmacies, already above even the UK's new list price. Irish pharmacy prices still vary by dose and by supplier, and they can change without notice — which is why we point readers to a live comparison rather than a number that goes stale. Our cheapest Mounjaro in Ireland guide is kept current.
Could a generic bring the price down?
This is the route most people mean when they ask. Generics lower prices because several manufacturers compete once a medicine's patent protection ends. For tirzepatide, that has not happened. As of this writing, no generic version has launched anywhere in the world.
There is early regulatory activity: the US FDA has agreed to review applications from Sandoz for generic tirzepatide, which was reported in mid-2026 (ET Pharma, June 2026). Accepting an application for review is a starting step, not an approval, and it concerns the US market. Published patent trackers put the main US protection well into the 2030s, with later dates for some secondary patents, though sources differ on the exact dates. Nothing here tells us when — or whether — an Irish price would change.
What about HSE cover or the Drugs Payment Scheme?
A different route to lower out-of-pocket cost is public reimbursement. At present, Mounjaro for weight management is not generally covered by the HSE for most people, and the Drugs Payment Scheme and medical card rules are narrow.
That may be looked at again: in October 2026 it was reported that an HSE group was due to meet to consider public funding for Mounjaro for weight loss — an early step in a formal process, not a decision (Newstalk, 12 October 2026). We cover where that stands, and what would have to change, in Will Mounjaro be free on the HSE?. Reimbursement decisions run through national assessment processes with their own timelines.
Are newer treatments a cheaper option?
New medicines are arriving, and more choice can change the market over time. An oral GLP-1 tablet, for example, is now in the picture — see our explainer on orforglipron and the weight-loss pill in Ireland. But a new product does not automatically mean a lower price, and different medicines suit different people. Which one is appropriate is a clinical decision for a doctor, not a price decision.
See how the claim works →What a sensible decision timeline looks like
Is waiting a good strategy?
That depends on your situation, and it is a question to put to a doctor rather than a price chart. A few honest points are worth holding in mind:
- A price fall is possible but unconfirmed, with no date attached to it.
- Waiting has its own cost if your health is the reason you are considering treatment.
- Medicine and dose decisions should be clinical first; cost is a real factor, but it should not be the only one.
If cost is the barrier, tell the doctor in your consultation. There are often ways to plan around it, including starting on the lowest dose and reviewing regularly — see how a supervised programme works.
How to keep an eye on prices without guessing
Rather than trying to predict the market, check the things that actually move prices: the supplier comparison in our monthly cost guide, official announcements from Lilly Ireland, and HSE or national reimbursement news. We update our own guides when something genuinely changes, so you do not need to refresh a dozen pages. For the wider picture, start with our complete guide to Mounjaro in Ireland or the overview of weight-loss injections in Ireland.
FAQs: will Mounjaro get cheaper in Ireland?
Will Mounjaro get cheaper in Ireland in 2026?
There is no announced price cut, and we cannot promise one. The most recent notable price change we can point to was an increase in the UK in September 2025. Irish pharmacy prices vary by supplier, so compare current figures rather than waiting on a prediction.
Is there a generic Mounjaro?
No. As of this writing, no generic tirzepatide has launched anywhere in the world. Regulatory applications have been accepted for review in the US, but that is an early step and not an approval.
Why did Mounjaro go up in price in the UK?
Lilly said the September 2025 increase was intended to address pricing inconsistencies compared with other developed countries. It applied to UK private prescriptions. Lilly separately confirmed to Irish media that it had no plans for price increases or a sales pause in Ireland.
Could the HSE cover Mounjaro?
Not currently for most people seeking it for weight management. In October 2026 it was reported that an HSE group was due to consider public funding, but no decision had been made. Any change would depend on national reimbursement decisions, which have their own assessment process and timelines. See our guide for the current position.
Should I wait for a lower price before starting?
That is a clinical and personal decision. A price drop is possible but unconfirmed, and delaying treatment has its own implications. A doctor can talk through whether treatment is appropriate for you and how to plan around cost.
Where can I compare current Mounjaro prices in Ireland?
Our cheapest Mounjaro in Ireland guide is kept up to date, and prices can differ by dose and supplier. Always confirm directly before you decide.
